Pyelonephritis in pregnancy - Treatment options for optimal outcomes

Authors
Citation
Da. Wing, Pyelonephritis in pregnancy - Treatment options for optimal outcomes, DRUGS, 61(14), 2001, pp. 2087-2096
Citations number
56
Categorie Soggetti
Pharmacology,"Pharmacology & Toxicology
Journal title
DRUGS
ISSN journal
00126667 → ACNP
Volume
61
Issue
14
Year of publication
2001
Pages
2087 - 2096
Database
ISI
SICI code
0012-6667(2001)61:14<2087:PIP-TO>2.0.ZU;2-R
Abstract
Acute pyelonephritis is one of the most common indications for antepartum h ospitalisation. When acute pyelonephritis is diagnosed, conventional treatm ent includes intravenous fluid and parenteral antibacterial administration. There are limited data by which to assess the superiority of one antibacte rial regimen over the other in terms of efficacy, patient acceptance and sa fety for the developing fetus. There is a small body of evidence to support the ambulatory treatment of pregnant women with pyelonephritis in the firs t and early second trimesters.